BCLI logo

BCLI Long Term Debt

Annual Long Term Debt

$672.00 K
-$1.99 M-74.79%

December 31, 2023


Summary


Performance

BCLI Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCLIbalance sheetmetrics:

Quarterly Long Term Debt

$271.00 K
-$125.00 K-31.57%

September 30, 2024


Summary


Performance

BCLI Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCLIbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

BCLI Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-74.8%-31.6%
3 y3 years-85.3%-31.6%
5 y5 years+100.0%-31.6%

BCLI Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-81.4%at low-93.1%at low
5 y5-year-85.3%at low-94.1%at low
alltimeall time-85.3%-100.0%-94.1%-100.0%

Brainstorm Cell Therapeutics Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$271.00 K(-31.6%)
Jun 2024
-
$396.00 K(-25.7%)
Mar 2024
-
$533.00 K(-20.7%)
Dec 2023
$672.00 K(-74.8%)
$672.00 K(-57.6%)
Sep 2023
-
$1.58 M(-18.2%)
Jun 2023
-
$1.94 M(-15.4%)
Mar 2023
-
$2.29 M(-14.1%)
Dec 2022
$2.67 M(-26.3%)
$2.67 M(-8.6%)
Sep 2022
-
$2.92 M(-10.6%)
Jun 2022
-
$3.26 M(-17.0%)
Mar 2022
-
$3.93 M(+8.7%)
Dec 2021
$3.62 M
$3.62 M(-3.9%)
Sep 2021
-
$3.77 M(-5.9%)
Jun 2021
-
$4.00 M(-4.2%)
DateAnnualQuarterly
Mar 2021
-
$4.18 M(-8.4%)
Dec 2020
$4.56 M(+313.6%)
$4.56 M(+1506.3%)
Sep 2020
-
$284.00 K(-49.2%)
Jun 2020
-
$559.00 K(-30.8%)
Mar 2020
-
$808.00 K(-26.7%)
Dec 2019
$1.10 M(>+9900.0%)
$1.10 M(-58.1%)
Sep 2019
-
$2.63 M(-7.3%)
Jun 2019
-
$2.84 M(-6.8%)
Mar 2019
-
$3.04 M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2007
$200.00 K
$200.00 K(-46.7%)
Sep 2007
-
$375.00 K(+1685.7%)
Dec 2002
-
$21.00 K(-34.8%)
Sep 2002
-
$32.20 K(-20.3%)
Jun 2002
-
$40.40 K

FAQ

  • What is Brainstorm Cell Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics annual long term debt year-on-year change?
  • What is Brainstorm Cell Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics quarterly long term debt year-on-year change?

What is Brainstorm Cell Therapeutics annual long term debt?

The current annual long term debt of BCLI is $672.00 K

What is the all time high annual long term debt for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high annual long term debt is $4.56 M

What is Brainstorm Cell Therapeutics annual long term debt year-on-year change?

Over the past year, BCLI annual long term debt has changed by -$1.99 M (-74.79%)

What is Brainstorm Cell Therapeutics quarterly long term debt?

The current quarterly long term debt of BCLI is $271.00 K

What is the all time high quarterly long term debt for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high quarterly long term debt is $4.56 M

What is Brainstorm Cell Therapeutics quarterly long term debt year-on-year change?

Over the past year, BCLI quarterly long term debt has changed by -$125.00 K (-31.57%)